NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Key Financials
Operating Income
$-4226473
↑ 64.4%
Revenue
$9.1M
↑ 163.5%
Net Income
$-3605374
↑ 70.7%
Gross Profit
$5.1M
↑ 376.2%
EPS (Diluted)
$-0.09
↑ 80.4%
Total Assets
$10.8M
↑ 100.9%
Shareholders' Equity
$7.1M
↑ 760.4%
Total Liabilities
$3.7M
↓ 18.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 7/2/2026 | View on SEC |
| 144 | 6/30/2026 | View on SEC |
| 424B5 | 6/12/2026 | View on SEC |
| 8-K | 6/12/2026 | View on SEC |
| 10-Q/A | 6/12/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
| SD | 5/29/2026 | View on SEC |
| 8-K | 5/22/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NMTC |
| Company Name | NEUROONE MEDICAL TECHNOLOGIES Corp |
| CIK | 1500198 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | DE |
| Phone | (952) 426-1383 |